Look for:

Our offer for

Research Detail

2022/02/16 / Erste Group Research

Sustained high margins for luxury brands

Recommendation changes: Mercedes-Benz, Pfizer, RWE, E.ON

Mercedes-Benz: Luxury strategy successful - record operating margin

Pfizer: Strong growth in previous year, outlook below expectations

RWE: Positive development in 2021 - stable margins expected this year
E.ON: High investments in energy networks, slower growth expected in 2022

PDF Download Download PDF (5.6MB)

General information

AuthorErste Group Research
Date2022/02/16
Languageen
Product nameRecommendation List
Topic in focusEquities
Economy in focusGermany, United Kingdom, United States
Currency in focusBritish Pound, Euro, US Dollar
Sector in focusAutomobiles & Parts, Banks, Basic Resources, Chemicals, Construction & Material, Financial Services, Food & Beverage, Health Care, Industrial Goods & Services, Insurance, Media, Oil & Gas, Personal & Household Goods, Retail, Technology, Telecommunications, Travel & Leisure, Utilities
Download

Related financial instruments

Page 1 of 4
Name  ISIN# Erste Group products
-DE00074720600
-US05675210850
-DE00054390040
-US88579Y10100
-DE00057856040
-DE00060484322
-RU00076616250
-DE000CBK10011
-CH00301704080
-GB00B24CGK770
-SE00001062700
-DE000ENAG9990
-US34537086000
-GB00BH4HKS390
-FR00102204750
-HK09410095390
ABBCH00122217160
AdidasDE000A1EWWW03
AlibabaUS01609W10270
AllianzDE00084040050
AlphabetUS02079K30590
Amadeus IT GroupES01090670190
Amazon.ComUS02313510670
AppleUS03783310050
ASMLNL00102732150



Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer